天眩清治疗眩晕、耳鸣的临床观察

目的 观察天眩清注射液对周围性眩晕、神经性耳鸣的治疗效果。方法 眩晕患者120例，耳鸣患者80例，各随机分为实验组及对照组，按观察项目、评定标准进行系列临床观察。结果 两实验组病例中，眩晕者总有效率93．3％，耳鸣者总有效率77．5％。结论 天眩清注射液对周围性眩晕、神经性耳鸣有显著疗效，为一种安全有效的制剂。     

胎儿心律失常的临床意义及预后的研究

目的 总结胎儿心律失常原因，进一步探讨其临床意义及对胎儿预后的影响。方法 采用回顾性分析方法，对26例胎儿心律失常孕妇的情况、胎儿心律失常的临床表现、诊断方法及长期随诊结果进行总结。结果 胎儿心律失常的发生率为0．2％。26例胎儿心律失常中，3例为胎儿心动过速(11．5％)，4例为胎儿心动过缓(15．4％)，19例为不规则胎儿心律(73．1％)；胎儿心律失常平均诊断孕周为35托周(15～41^ 1周)。26例中22例为产前胎心听诊时发现胎儿心律失常；1例为妊娠15周超声检查时发现胎儿心律失常；3例胎心监测发现胎儿心律失常。17例产前进行了胎儿超声心动检查，心脏结构未见异常，其中6例胎儿超声心动检查提示胎儿房性早搏，占35．3％，余未见异常。产后新生儿均存活，随诊24例(92．3％)，16例新生儿进行了超声心动检查，其中2例诊断为先天性心脏病，均为房间膈缺损。先天性心脏病新生儿在心律失常胎儿中发生率为7．7％。结论 大多数心律失常的胎儿预后是好的，心脏畸形的发生率很低。对于持续性心率慢的胎儿，需注意心脏结构异常的存在；对于心律失常胎儿的处理采用期待疗法，根据产科指征决定终止妊娠的方式。     

三种输卵管疏通术治疗后发生输卵管妊娠的临床分析

目的 :了解输卵管疏通术后发生输卵管妊娠的危险因素及其相应对策。方法 :回顾性分析 6 9例输卵管性不孕者分别经三种输卵管疏通术后发生输卵管妊娠 (TP)的患者 ,分成 3组 ,比较 3组疏通术前子宫输卵管碘油造影(HSG)结果和疏通术后通畅与非通畅输卵管的TP发生率。结果 :疏通术前 ,示输卵管柔软 5 7条 (34例 ) ,发生TP 2 1例(6 1.8% ) ,而欠柔软 /僵硬 79条 (5 6例 ) ,发生TP 4 8例 (85 7% ) ,两者差异有显著意义 (P <0 0 5 ) ;输卵管周围有无粘连者TP发生率差异也存在显著意义 (P <0 0 5 )。无论畅与不畅 ,3组术后TP发生率间差异无显著意义 (P >0 0 5 )。结论 :疏通术前HSG提示输卵管欠柔软、僵硬以及存在周围粘连者可能是疏通治疗后输卵管妊娠发生的危险因素。对于此类病变严重的输卵管不宜选择疏通术治疗。     

高压氧治疗对脑外伤患者血糖影响的比较研究

目的 探讨高压氧治疗对脑外伤患者血糖的影响。方法 将100例脑外伤患者随机分为治疗组和对照组，分别测量治疗前后两组患者血糖浓度。结果 高压氧治疗后脑外伤患者血糖浓度较对照组明显降低。结 论高压氧治疗能使脑外伤后升高的血糖降低，促进受损伤脑组织修复。     

灯盏细辛注射液合雅施达治疗早期糖尿病肾病30例——附西药对照组28例

观察灯盏细辛注射液联合雅施达治疗早期糖尿病肾病 (DN)的疗效。 5 8例患者随机分为 2组 ,在采用口服降糖药或胰岛素有效控制血糖水平的基础上 ,治疗组服用雅施达治疗的同时 ,联合灯盏细辛注射液治疗 ,对照组单服雅施达 ,两组均治疗 4周。结果 :治疗组的 2 4h尿微量白蛋白 ,血糖 ,血脂 ,血 β2 -MG及血液流变学等指标较对照组均有显著改善 (P <0 0 5或P <0 0 1)。结论 :中西医结合治疗早期DN疗效明显优于单纯的西药治疗     

Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial.

PURPOSE: To determine the response rate, time to disease progression, survival duration and rate, and toxicity with the combination of cetuximab and gemcitabine in patients with epidermal growth factor receptor (EGFR)-expressing advanced pancreatic cancer. PATIENTS AND METHODS: Patients with measurable locally advanced or metastatic pancreatic cancer who had never received chemotherapy for their advanced disease and had immunohistochemical evidence of EGFR expression were eligible for the multicenter phase II trial. Patients were treated with cetuximab at an initial dose of 400 mg/m(2), followed by 250 mg/m(2) weekly for 7 weeks. Gemcitabine was administered at 1,000 mg/m(2) for 7 weeks, followed by 1 week of rest. In subsequent cycles, cetuximab was administered weekly, and gemcitabine was administered weekly for 3 weeks every 4 weeks. RESULTS: Sixty-one patients were screened for EGFR expression, 58 patients (95%) had at least 1+ staining, and 41 were enrolled onto the trial. Five patients (12.2%) achieved a partial response, and 26 (63.4%) had stable disease. The median time to disease progression was 3.8 months, and the median overall survival duration was 7.1 months. One-year progression-free survival and overall survival rates were 12% and 31.7%, respectively. The most frequently reported grade 3 or 4 adverse events were neutropenia (39.0%), asthenia (22.0%), abdominal pain (22.0%), and thrombocytopenia (17.1%). CONCLUSION: Cetuximab in combination with gemcitabine showed promising activity against advanced pancreatic cancer. Further clinical investigation is warranted.     

Treatment of 78 cases of shoulder periarthritis by warming-needle method

Jiansanzhen, Tianzong (SI 11), Jugu (LI 16), Jianzhen (SI 9), Binao (LI 14) and Quchi (LI 11) were given warming-needle moxibustion to treat shoulder periarthritis in 78 cases, and the result showed total effective rate was 97.4%. Author: LI Jian-wu (1955-), male, junior consultant doctor Translator: WU Xue-fei     

EXPRESSION OF p16,CYCLIN D1 AND RB PROTEIN IN GASTRIC CARCINOMA AND PREMALIGNANT LESIONS

Gastric carcinoma is one of the most serious diseases in mankind. Its pathogenesis has not been understood very clearly. Recent researches suggested that oncogenes (such as cyclin D1), antioncogenes (ie., p16, Rb) and cell cycle played an important role in the pathogenesis of gastric carcinoma. But there are few reports about the relationship between these genes in gastric carcinoma and gastric premalignant lesions. In this study, we will discuss these problems. MATERIALS AND METHO…     

经去颧弓扩大颞下入路切除海绵窦,岩尖,上斜坡肿瘤

本文介绍采用改进的去颧弓扩大颞下入路手术治疗８例位于或累及海绵窦、岩骨尖部、上斜坡、天幕游离前外缘肿瘤患者。该方法的要点是断去颧弓，扇形形成颞肌瓣，翻向颧弓断段以下，咬除蝶骨嵴外侧部分，形成低位颞额骨窗，仅轻度上抬颞叶，则可充分暴露病变范围。由于手术空间扩大，更利于肿瘤切除。本组８例均达到全部或大部分切除，患者术后均得以康复，原有体征不同程度改善。     

The effect of the H2 antagonist cimetidine on the numbers of CD4+ and CD8+ cells in the nasal mucosa of patients with allergic rhinitis

This paper reports the effects of the H₂ antagonist cimetidine on the number of CD4⁺ and CD8⁺ cells in nasal mucosa and the IgE level of nasal secretions in patients with allergic rhinitis. The results showed the numbers of CD4⁺ cells were greater than the numbers of CD8⁺ cells in nasal mucosa, both in the patients with allergic rhinitis and normal subjects, but the ratio of CD4⁺ : CD8⁺ cells was much higher in the patients with allergic rhinitis. After treatment with cimetidine locally for 4 weeks, the numbers of CD4⁺ cells fell and the numbers of CD8⁺ cells increased in the patients with allergic rhinitis. The high IgE level of nasal secretion of the patients with allergic rhinitis was much reduced after treatment with cimetidine. The results suggest that there are high numbers of CD4⁺ cells and lower numbers of CD8⁺ cells in the nasal mucosa and a high level of IgE in the nasal secretions of the patients with allergic rhinitis. Treatment with cimetidine locally may be of some value to relieve the clinical symptoms of allergic rhinitis.